Get the Stockscreener App
8.70
0.23%
0.02
After Hours:
8.74
0.04
+0.46%
Novavax Inc Stock (NVAX) Forecast
The Novavax Inc (NVAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.4308, representing a -72.06% decrease from the current price of $8.70. The highest analyst price target is $2.8085, and the lowest is $2.0531.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 94.77
(+989.27% Upside)
Is Novavax Inc (NVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.62 | Neutral |
| STOCH(9,6) | 40.99 | Neutral |
| STOCHRSI(14) | 39.31 | Neutral |
| MACD(12,26) | -0.0837 | Buy |
| ADX(14) | 16.33 | Neutral |
| William %R | -64.81 | Neutral |
| CCI(14) | -45.47 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.903
Sell
|
8.806
Sell
|
| MA20 |
8.7815
Sell
|
8.81
Sell
|
| MA50 |
9.2084
Sell
|
9.4272
Sell
|
| MA100 |
10.83
Sell
|
10.17
Sell
|
| MA200 |
10.51
Sell
|
9.9764
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NVAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NVAX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.62 indicates that NVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.99 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 39.31 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.33 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -45.47 indicates that NVAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novavax Inc financial reports and earnings history, Novavax Inc (NVAX) stock could reach $4.1836 by 2030, $5.3488 by 2040 and $83.18 by 2050. See the projected annual prices until 2050 of the Novavax Inc stock below:
- Novavax Inc (NVAX) is expected to reach an average price of $2.8087 in 2035, with a high prediction of $4.7215 and a low estimate of $2.5387. This indicates an $-67.72% rise from the last recorded price of $8.70.
- Novavax Inc (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3442, representing an $-61.56% surge from its current level. The forecast ranges from a conservative $2.508 to a sky-high $5.3488.
- Our analysts predict Novavax Inc (NVAX) to jump 18.33% by 2045, soaring from $10.22 to an average price of $10.29, potentially reaching $27.34. While $10.22 is the low estimate, the potential upside is significant.
- Novavax Inc (NVAX) stock is expected to climb by 2050, reaching an average of $74.50, a $756.27% jump from its current level. However, a wide range of estimates exists, with high and low targets of $83.18 and $58.01, respectively, highlighting the market's uncertainty.
Novavax Inc Stock (NVAX) Year by Year Forecast
Novavax Inc Stock (NVAX) Price Forecast for 2025
Novavax Inc Stock (NVAX) is expected to reach an average price of $94.77 in 2025, with a high prediction of $187.67 and a low estimate of $1.8639. This indicates an +989.27% rise from the last recorded price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.6235 | $2.0531 | $2.8085 | -69.85% |
| February, 2025 | $5.7257 | $1.8639 | $8.1539 | -34.19% |
| March, 2025 | $13.86 | $4.7675 | $15.92 | +59.29% |
| April, 2025 | $11.57 | $4.9983 | $13.16 | +33.01% |
| May, 2025 | $22.03 | $11.45 | $24.57 | +153.19% |
| June, 2025 | $41.88 | $14.65 | $44.23 | +381.34% |
| July, 2025 | $63.17 | $38.75 | $64.32 | +626.04% |
| August, 2025 | $92.62 | $57.56 | $110.03 | +964.63% |
| September, 2025 | $168.56 | $93.52 | $187.67 | +1,837% |
| October, 2025 | $91.21 | $84.94 | $179.97 | +948.38% |
| November, 2025 | $106.64 | $81.50 | $124.82 | +1,126% |
| December, 2025 | $79.00 | $76.79 | $120.21 | +808.10% |
Novavax Inc Stock (NVAX) Price Forecast for 2026
The predicted value for Novavax Inc (NVAX) in 2026 is set at an average of $202.45. Estimates vary from a peak of $330.00 to a trough of $74.89, indicating an +2,227% surge from the present price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $123.99 | $74.89 | $130.30 | +1,325% |
| February, 2026 | $123.11 | $104.42 | $148.81 | +1,315% |
| March, 2026 | $125.75 | $105.39 | $135.89 | +1,345% |
| April, 2026 | $276.21 | $119.58 | $330.00 | +3,075% |
| May, 2026 | $226.58 | $145.72 | $275.48 | +2,504% |
| June, 2026 | $178.08 | $157.42 | $239.81 | +1,947% |
| July, 2026 | $130.04 | $115.47 | $262.02 | +1,395% |
| August, 2026 | $208.04 | $126.93 | $212.86 | +2,291% |
| September, 2026 | $186.96 | $167.16 | $227.86 | +2,049% |
| October, 2026 | $188.25 | $170.38 | $245.02 | +2,064% |
| November, 2026 | $236.92 | $190.37 | $258.37 | +2,623% |
| December, 2026 | $205.44 | $196.39 | $276.18 | +2,261% |
Novavax Inc Stock (NVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novavax Inc (NVAX) is $134.13, with a high forecast of $234.91 and a low forecast of $33.35. This indicates an +1,442% increase from the last price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $132.98 | $119.75 | $190.79 | +1,428% |
| February, 2027 | $190.74 | $128.48 | $199.88 | +2,092% |
| March, 2027 | $215.73 | $136.66 | $227.41 | +2,380% |
| April, 2027 | $109.24 | $99.52 | $234.91 | +1,156% |
| May, 2027 | $87.76 | $64.80 | $105.95 | +908.70% |
| June, 2027 | $70.16 | $67.93 | $99.82 | +706.39% |
| July, 2027 | $72.09 | $64.26 | $84.04 | +728.65% |
| August, 2027 | $45.10 | $44.48 | $76.10 | +418.39% |
| September, 2027 | $53.75 | $39.79 | $61.68 | +517.80% |
| October, 2027 | $38.71 | $33.35 | $55.95 | +344.90% |
| November, 2027 | $74.59 | $37.85 | $75.24 | +757.40% |
| December, 2027 | $39.95 | $36.64 | $73.81 | +359.22% |
Novavax Inc Stock (NVAX) Price Forecast for 2028
In 2028, Novavax Inc (NVAX) is projected to reach an average price of $23.33, with a high projection of $42.50 and a low estimate of $4.1541. This indicates an +168.15% rise from the last price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.88 | $28.81 | $42.50 | +231.95% |
| February, 2028 | $16.70 | $16.35 | $31.86 | +91.92% |
| March, 2028 | $20.78 | $14.50 | $23.15 | +138.80% |
| April, 2028 | $15.05 | $14.83 | $24.17 | +73.02% |
| May, 2028 | $8.182 | $7.8802 | $17.07 | -5.95% |
| June, 2028 | $10.08 | $7.2738 | $12.23 | +15.85% |
| July, 2028 | $8.4164 | $8.0164 | $11.18 | -3.26% |
| August, 2028 | $5.0655 | $4.7955 | $8.8183 | -41.78% |
| September, 2028 | $7.0127 | $4.1541 | $7.5027 | -19.39% |
| October, 2028 | $6.2699 | $5.4499 | $8.2363 | -27.93% |
| November, 2028 | $6.1889 | $5.2053 | $9.9217 | -28.86% |
| December, 2028 | $6.0061 | $5.1361 | $7.0975 | -30.96% |
Novavax Inc Stock (NVAX) Price Forecast for 2029
The 2029 price forecast for Novavax Inc Stock (NVAX) is $5.5239 on average, with a high prediction of $8.8977 and a low estimate of $2.15. This represents an -36.51% decrease from the previous price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.8651 | $5.4779 | $8.7597 | -9.60% |
| February, 2029 | $6.6423 | $5.4337 | $8.1923 | -23.65% |
| March, 2029 | $6.3095 | $5.8995 | $8.8977 | -27.48% |
| April, 2029 | $5.6567 | $5.3253 | $6.7549 | -34.98% |
| May, 2029 | $4.8557 | $4.5657 | $6.1057 | -44.19% |
| June, 2029 | $4.1929 | $3.9193 | $5.1275 | -51.81% |
| July, 2029 | $3.4302 | $3.4302 | $4.6747 | -60.57% |
| August, 2029 | $2.6392 | $2.5892 | $3.972 | -69.66% |
| September, 2029 | $3.9364 | $2.1752 | $4.1064 | -54.75% |
| October, 2029 | $3.3554 | $2.8782 | $4.6982 | -61.43% |
| November, 2029 | $2.6326 | $2.4726 | $3.6072 | -69.74% |
| December, 2029 | $2.81 | $2.15 | $5.88 | -67.70% |
Novavax Inc Stock (NVAX) Price Forecast for 2030
Novavax Inc Stock (NVAX) is expected to reach an average price of $7.107 in 2030, with a high forecast of $14.15 and a low forecast of $0.0683. This signifies an -18.31% decrease from the last price of $8.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.313 | $0.9481 | $4.1836 | -84.91% |
| February, 2030 | $1.3024 | $1.1524 | $3.4552 | -85.03% |
| March, 2030 | $0.6559 | $0.3932 | $1.216 | -92.46% |
| April, 2030 | $2.2613 | $0.3589 | $4.4877 | -74.01% |
| May, 2030 | $1.4393 | $1.3593 | $4.0021 | -83.46% |
| June, 2030 | $0.8237 | $0.5437 | $1.5129 | -90.53% |
| July, 2030 | $0.1317 | $0.0683 | $1.2345 | -98.49% |
| August, 2030 | $0.4242 | $0.0953 | $2.0389 | -95.12% |
| September, 2030 | $0.3556 | $0.2777 | $1.1406 | -95.91% |
| October, 2030 | $4.0786 | $0.076 | $6.3678 | -53.12% |
| November, 2030 | $4.753 | $3.7622 | $14.15 | -45.37% |
| December, 2030 | $11.80 | $3.2266 | $12.03 | +35.60% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):